| New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people A Holt, GH Gislason, M Schou, B Zareini, T Biering-Sørensen, M Phelps, ... European heart journal 41 (32), 3072-3079, 2020 | 118 | 2020 |
| Incidence of new-onset and worsening heart failure before and after the COVID-19 epidemic lockdown in Denmark: a nationwide cohort study C Andersson, T Gerds, E Fosbøl, M Phelps, J Andersen, M Lamberts, ... Circulation: Heart Failure 13 (6), e007274, 2020 | 111 | 2020 |
| Sleep apnea, the risk of developing heart failure, and potential benefits of continuous positive airway pressure (CPAP) therapy A Holt, J Bjerre, B Zareini, H Koch, P Tønnesen, GH Gislason, OW Nielsen, ... Journal of the American Heart Association 7 (13), e008684, 2018 | 41 | 2018 |
| Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish … A Holt, P Blanche, B Zareini, D Rajan, M El-Sheikh, AM Schjerning, ... European heart journal 42 (9), 907-914, 2021 | 38 | 2021 |
| Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study B Zareini, R Rørth, A Holt, UM Mogensen, C Selmer, G Gislason, M Schou, ... Cardiovascular Diabetology 18, 1-10, 2019 | 35 | 2019 |
| Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study JE Strange, A Holt, P Blanche, G Gislason, C Torp-Pedersen, ... European Heart Journal 42 (30), 2899-2908, 2021 | 13 | 2021 |
| Influence of inhibitors of the renin–angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients A Holt, I Mizrak, M Lamberts, PL Madsen Journal of Hypertension 38 (8), 1612-1613, 2020 | 12 | 2020 |
| Bleeding risk following systemic fluconazole or topical azoles in patients with atrial fibrillation on apixaban, rivaroxaban, or dabigatran A Holt, JE Strange, PV Rasmussen, P Blanche, N Nouhravesh, ... The American Journal of Medicine 135 (5), 595-602. e5, 2022 | 11 | 2022 |
| Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017 A Arulmurugananthavadivel, A Holt, S Parveen, M Lamberts, GH Gislason, ... European Heart Journal-Quality of Care and Clinical Outcomes 8 (7), 750-760, 2022 | 10 | 2022 |
| On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects PF Blanche, A Holt, T Scheike Lifetime data analysis 29 (2), 441-482, 2023 | 9 | 2023 |
| Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants A Holt, P Blanche, B Zareini, PV Rasmussen, JE Strange, D Rajan, ... Heart 108 (8), 626-632, 2022 | 9 | 2022 |
| Adverse events associated with coprescription of phosphodiesterase type 5 inhibitors and oral organic nitrates in male patients with ischemic heart disease: a case-crossover study A Holt, P Blanche, AKG Jensen, N Nouhravesh, D Rajan, MH Jensen, ... Annals of Internal Medicine 175 (6), 774-782, 2022 | 8 | 2022 |
| Heart failure following anti-inflammatory medications in patients with type 2 diabetes mellitus A Holt, JE Strange, N Nouhravesh, SK Nielsen, ME Malik, AM Schjerning, ... Journal of the American College of Cardiology 81 (15), 1459-1470, 2023 | 7 | 2023 |
| Prognosis of acute coronary syndrome stratified by cancer type and status-a nationwide cohort study N Nouhravesh, JE Strange, J Tønnesen, A Holt, CF Andersen, MH Jensen, ... American Heart Journal 256, 13-24, 2023 | 5 | 2023 |
| Nursing home admission following transcatheter aortic valve replacement: a Danish nationwide cohort study JE Strange, C Sindet-Pedersen, A Holt, MP Andersen, C Torp-Pedersen, ... Cardiovascular Interventions 16 (2), 179-188, 2023 | 5 | 2023 |
| The effect of discontinuing beta-blockers after different treatment durations following acute myocardial infarction in optimally treated, stable patients without heart failure … A Halili, A Holt, TE Eroglu, S Haxha, B Zareini, C Torp-Pedersen, ... European Heart Journal-Cardiovascular Pharmacotherapy 9 (6), 553-561, 2023 | 4 | 2023 |
| Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study A Holt, N Nouhravesh, JE Strange, S Kinnberg Nielsen, AM Schjerning, ... European Heart Journal 45 (6), 475-484, 2024 | 3 | 2024 |
| Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular disease A Holt, B Batinica, J Liang, A Kerr, S Crengle, B Hudson, S Wells, ... European Journal of Preventive Cardiology 31 (2), 218-227, 2024 | 3 | 2024 |
| Patient mortality following new‐onset heart failure stratified by cancer type and status N Nouhravesh, JE Strange, A Holt, J Tønnesen, CF Andersen, SK Nielsen, ... European Journal of Heart Failure 25 (10), 1859-1867, 2023 | 3 | 2023 |
| Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era–a Danish, nationwide, and registry-based cohort study A Holt, B Zareini, D Rajan, M Schou, GH Gislason, AM Schjerning, ... European Heart Journal 41 (Supplement_2), ehaa946. 3390, 2020 | 3 | 2020 |
